← Back
$KLRA All transactions

Kailera Therapeutics, Inc.

C

$ Value

$0

Shares

17,857,143

Price

$0

Filed

Apr 20

Insider

Name

Kaplan Andrew T.

Title

CIK

0001752059

Roles

Director 10% Owner

Transaction Details

Transaction Date

2026-04-20

Code

C

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

Footnotes

Each share of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1:1 basis upon the closing of the Issuer's initial public offering. These securities had no expiration date. | The options vest and become exercisable as to 100% of the underlying shares on April 16, 2027, subject to Mr. Kaplan's continued service through each such vesting date. | Represents securities held directly by BCPE Perseus Investor, LP ("BCPE Perseus"). | Mr. Kaplan is a Partner of Bain Capital Investors, LLC ("BCI"). BCI is the ultimate general partner of BCPE Perseus. As a result, Mr. Kaplan may be deemed to share voting and dispositive power with respect to the securities held by BCPE Perseus. Mr. Kaplan disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Filing Info

Accession No.

0001193125-26-164388

Form Type

4

Issuer CIK

0002096997

Kaplan Andrew T.'s History

Date Ticker Type Value
2026-04-20 KLRA C
2026-04-20 KLRA $134.4M
2026-04-20 KLRA C $0
2026-04-16 KLRA A $0

Other Insiders at KLRA (90d)

Insider Bought Sold Last
Kaplan Andrew T. / BAIN CAPITAL INVESTORS LLC $134.4M 2026-04-20
Bain Capital Life Sciences Investors, LLC / Koppel Adam $25.0M 2026-04-20
RTW INVESTMENTS, LP $8.0M 2026-04-20
BAIN CAPITAL INVESTORS LLC 2026-04-20
MILLIGAN JOHN F 2026-04-16
Renaud Ronald C JR
CEO & President
2026-04-16
MACKAY MARTIN 2026-04-16
Koppel Adam 2026-04-20
Pagan Douglas W.
Chief Financial Officer
2026-04-16
Bain Capital Life Sciences Investors, LLC 2026-04-20
Burgess Paul D.
See Remarks
2026-04-16
Cloghessy Paula
Chief People Officer
2026-04-16
Kaplan Andrew T. 2026-04-20
Clyburn Frank 2026-04-16
Hite Christopher 2026-04-16
Akamine Scott
Chief Legal Officer
2026-04-16
Jiangsu Hengrui Pharmaceuticals Co., Ltd. 2026-04-20
Coleman Jamie Beth
Chief Commercial Officer
2026-04-16
Wasserman Scott M.
Chief Medical Officer
2026-04-16